Navigation Links
KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings
Date:5/30/2008

p>

For further information about KV Pharmaceutical Company, please visit the Company's corporate website at http://www.kvpharmaceutical.com.

Safe Harbor

The information in this release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning KV's operations, future results and prospects. Such statements may be identified by the use of words like "plans", "expect", "aim", "believe", "projects", "anticipates", "commit", "intend", "estimate", "will", "should", "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, statements about the Company's anticipated SEC filings, strategy for growth, product development, product launches, regulatory approvals, market position, market share increases, acquisitions, revenues, expenditures and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, KV provides the following cautionary statements identifying important economic, political and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ding may lead to new therapies for preterm labor ,...esearchers say they,ve found the switch that activ...ildbirth, a finding that may lead to therapies for...rmally binds the protein IP on the surface of thes...active during pregnancy. , But researchers fro...
(Date:11/21/2008)...cial meeting of shareholders to be held on January...irstCall/ - Med-Emerg International Inc. ("MedEmer...rs of health services, announced today that it has...or Court of Justice concerning its previously anno...uant to which AIM Health Group Inc. ("AIM") will a...
(Date:11/21/2008)...USTON(Nov. 21, 2008)The University of Texas Health...am, Training Excellence in Aging Studies (TEXAS), ...ugh a prestigious $2 million award from the Donald...ing funds., "This will allow us to teach geriatri...nior medical student to practicing physicians. Wit...
(Date:11/21/2008)...ELAND, Colo., Nov. 21 He... it will present at the New York Society of,Secur...arma Conference on,December 2, 2008 at 1177 Avenu... presentation is scheduled to begin at 9:35 a.m. E... available via live webcast and for two weeks,fol...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
...protein in the seasonal flu vaccine may trigger an...uenza vaccine that health officials advice people ...ection against the H5N1 virus, commonly known as b...gators at St. Jude Children's Research Hospital. ...
...re is no convincing evidence that taking omega-3 f...says Drug// and Therapeutics Bulletin (DTB). And ...ve depression when used in combination with antide...vidence from circumstantial research has suggested...
...ldren snacking in big groups eat almost a third mo...als research published// ahead of print in the Arc...alysed the eating behaviour of 54 children between... they were in a group of nine children and when th...
...an from Naples, New York who was diagnosed with lu...Schenk who is a former Marine// is currently suffe... given him a year or at the maximum eighteen month...n this lottery. But the irony that is accompanying...
Other Medicine News:Health News:Influenza Virus also Protects Against H5N1 2Health News:Influenza Virus also Protects Against H5N1 3
(Date:11/19/2008)...ogen, a contract development and,manufacturing or...e first,phase launch of its contract facility in ...ess the process, facility and capacity problems co...ed, low-volume clinical and,early-stage commercia...es can invest over $100 million and four years to ...
(Date:11/18/2008)...lington Medical Resources (AMR), a,provider of pr...nd diagnostic,imaging industries, finds that over...n the U.S. during the third quarter of 2008. Privi...bulin (IVIG) and was launched in the first,quarte...d plasma of thousands,of donors and is used to tr...
(Date:11/13/2008)...FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ), a le...ium,diagnostics, medical imaging systems and surgi...eeds of women, today announced the results of the,... Cervista HPV high-risk,test is currently under re...launched in the European Union (EU) early in 2009....
(Date:11/12/2008)...tson, Marilyn & James Simons and,Sherry Lansing at...2 J. Craig Venter,Ph.D...stitute (JCVI), was,awarded the Double Helix Medal...mber 6th at a gala event in New York City., Dr. V...r. James D.,Watson for making each of their indivi...
Breaking Medicine Technology:Isogen Launches Major New Facility to Address Global Biopharma Demand 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2High Blood Pressure on Increase Among American Women 11555 1High Blood Pressure on Increase Among American Women 11555 2NeoStrata Research Validates Anti Aging Benefits of At Home AHA Peels As Complement to In Office Non Invasive Cosmetic Procedures 11552 1NeoStrata Research Validates Anti Aging Benefits of At Home AHA Peels As Complement to In Office Non Invasive Cosmetic Procedures 11552 2Charlotte IVF Experts Issue Urgent Call for Egg Donors Eye New Recruiting Tools 11549 1Charlotte IVF Experts Issue Urgent Call for Egg Donors Eye New Recruiting Tools 11549 2First Responders Acquire Revolutionary MyClyns 28TM 29 Protective Spray 11546 1First Responders Acquire Revolutionary MyClyns 28TM 29 Protective Spray 11546 2First Responders Acquire Revolutionary MyClyns 28TM 29 Protective Spray 11546 3
... April 19, 2007 /PRNewswire-FirstCall/ --,VioQuest...rmaceutical company focused on acquiring, developi...announced data from its,preclinical studies of VQD...e treatment of solid and hematologic tumors.,Pre-c...l 2007,Annual Meeting of the American Association ...
...07 /PRNewswire/ -- Addex Pharmaceuticals,announced...oof of,concept trial with its lead compound ADX100...ts primary objective, the absence of,pain at 2 hou...d,also showed trends towards improvement in pain-f...er time points. ADX10059 has,already recently demo...
Other Medicine Technology:VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: